Advertisement
Screener

Todos Medical Ltd. Diluted Shares Outstanding (Weighted Average)

Todos Medical Ltd. Diluted Shares Outstanding (Weighted Average)

Todos Medical Ltd. reported Diluted Shares Outstanding (Weighted Average) of 1.04 billion shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.

Discontinued › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2022-05-16

  • Todos Medical Ltd. weighted average number of shares outstanding, diluted for the quarter ending 2022-03-31 was 1.04B shares, a 123.37% increase year-over-year.
  • Todos Medical Ltd. weighted average number of shares outstanding, diluted for the quarter ending 2021-09-30 was 1.91T shares, a 202.58% increase year-over-year.
  • Todos Medical Ltd. weighted average number of shares outstanding, diluted for the quarter ending 2021-06-30 was 706.24M shares, a 272.44% increase year-over-year.
  • Todos Medical Ltd. weighted average number of shares outstanding, diluted for the quarter ending 2021-03-31 was 464.21M shares, a 233.43% increase year-over-year.
Period endWeighted Average Number of Shares Outstanding, Diluted 3 monthWeighted Average Number of Shares Outstanding, Diluted 6 monthWeighted Average Number of Shares Outstanding, Diluted 9 month
2022-03-311.04B shares
10-Q · filed 2022-05-16
2021-09-301.91T shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
956.64B shares
derived: average of 2 quarters · filed 2021-11-15
637.92B shares
10-Q · filed 2021-11-15
2021-06-30706.24M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-24
585.23M shares
10-Q · filed 2021-09-24
2021-03-31464.21M shares
10-Q · filed 2022-05-16
2020-09-30632.09B shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
316.14B shares
derived: average of 2 quarters · filed 2021-11-15
210.81B shares
10-Q · filed 2021-11-15
2020-06-30189.62M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-24
164.42M shares
10-Q · filed 2021-09-24
2020-03-31139.22M shares
10-Q · filed 2021-06-22